Us Health Regulator
-
{
- All
- News
- Videos
-
Glenmark Gets Final Nod From US Drug Regulator for Skin Cream
Glenmark Generics Inc USA, the subsidiary of Glenmark Generics Ltd, has been granted final approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Fluocinonide cream USP (0.1 per cent), Glenmark Pharmaceuticals said in a statement.
-
Zydus Gets US Regulator's Approval To Market Generic Drug For Myxedema Coma
Zydus Lifesciences today said it has received approval from the US health regulator to market a generic product which is used to treat myxedema coma.
-
Zydus Gets US Regulator's Approval To Market Generic Drug For Myxedema Coma
Zydus Lifesciences today said it has received approval from the US health regulator to market a generic product which is used to treat myxedema coma.
-
Zydus Gets US Regulator's Approval To Market Generic Drug For Myxedema Coma
Zydus Lifesciences today said it has received approval from the US health regulator to market a generic product which is used to treat myxedema coma.
-
USFDA issues Warning Letter To Divis Labs For Vishakhapatnam Unit
The United States Food and Drug Administration (USFDA) has issued warning letter for the company's Unit-II at Vishakhapatnam, Divis Laboratories said in a BSE filing.
-
Sharon Bio-Medicine Gets USFDA Nod For API Plant In Taloja
Sharon Bio-Medicine on Tuesday said it has received approval from the US health regulator for its API plant at Taloja in Maharashtra.
-
Glenmark Gets USFDA Nod For Skin Lesion Treatment Gel
Glenmark Pharmaceuticals has received final approval from the US health regulator for generic Diclofenac Sodium gel used for treatment of skin lesion.
-
Aurobindo Pharma Gets USFDA Nod For Two Drugs
Aurobindo Pharma on Wednesday said it has received final approval from the US health regulator to manufacture and market generic version of heartburn relief medicine Famotidine tablets.
-
Jubilant Life Zooms 10% on USFDA Nod for Anti-Depressant Drug
Jubilant Life Sciences shares soared almost 10 per cent, to touch its fresh 52-week high on Tuesday, as the company received final approval from the US health regulator for its generic version of anti-depressant Paxil tablets.
-
Strides Shasun Gets USFDA Nod to Market Dutasteride Capsules
Strides Shasun has received approval from the US health regulator to market Dutasteride capsules, used in treating enlarged prostate gland, in the American market.
-
Pathway Launches 'Liquid Biopsy' to Find Cancer in Healthy People
Pathway Genomics, a company known for pushing the boundaries of direct-to-consumer genetic testing, on Thursday will launch a cancer screening test designed to detect bits of cancer DNA in the blood of otherwise healthy people.
-
Pathway Launches 'Liquid Biopsy' to Find Cancer in Healthy People
Pathway Genomics, a company known for pushing the boundaries of direct-to-consumer genetic testing, on Thursday will launch a cancer screening test designed to detect bits of cancer DNA in the blood of otherwise healthy people.
-
US FDA Approves 'Female Viagra' With Strong Warning
The first drug to treat low sexual desire in women won approval from US health regulators on Tuesday, but with a warning about potentially dangerous low blood pressure and fainting side effects, especially when taken with alcohol.
-
US Health Regulator Says Lead in Maggi Within Acceptable Levels
As a ban continues in India on Nestle's Maggi noodles, the US health regulator USFDA has said its tests have found the lead level in the popular instant food within acceptable levels for US consumers.
-
Glenmark Gets Final Nod From US Drug Regulator for Skin Cream
Glenmark Generics Inc USA, the subsidiary of Glenmark Generics Ltd, has been granted final approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Fluocinonide cream USP (0.1 per cent), Glenmark Pharmaceuticals said in a statement.
-
Glenmark Gets Final Nod From US Drug Regulator for Skin Cream
Glenmark Generics Inc USA, the subsidiary of Glenmark Generics Ltd, has been granted final approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Fluocinonide cream USP (0.1 per cent), Glenmark Pharmaceuticals said in a statement.
-
Zydus Gets US Regulator's Approval To Market Generic Drug For Myxedema Coma
Zydus Lifesciences today said it has received approval from the US health regulator to market a generic product which is used to treat myxedema coma.
-
Zydus Gets US Regulator's Approval To Market Generic Drug For Myxedema Coma
Zydus Lifesciences today said it has received approval from the US health regulator to market a generic product which is used to treat myxedema coma.
-
Zydus Gets US Regulator's Approval To Market Generic Drug For Myxedema Coma
Zydus Lifesciences today said it has received approval from the US health regulator to market a generic product which is used to treat myxedema coma.
-
USFDA issues Warning Letter To Divis Labs For Vishakhapatnam Unit
The United States Food and Drug Administration (USFDA) has issued warning letter for the company's Unit-II at Vishakhapatnam, Divis Laboratories said in a BSE filing.
-
Sharon Bio-Medicine Gets USFDA Nod For API Plant In Taloja
Sharon Bio-Medicine on Tuesday said it has received approval from the US health regulator for its API plant at Taloja in Maharashtra.
-
Glenmark Gets USFDA Nod For Skin Lesion Treatment Gel
Glenmark Pharmaceuticals has received final approval from the US health regulator for generic Diclofenac Sodium gel used for treatment of skin lesion.
-
Aurobindo Pharma Gets USFDA Nod For Two Drugs
Aurobindo Pharma on Wednesday said it has received final approval from the US health regulator to manufacture and market generic version of heartburn relief medicine Famotidine tablets.
-
Jubilant Life Zooms 10% on USFDA Nod for Anti-Depressant Drug
Jubilant Life Sciences shares soared almost 10 per cent, to touch its fresh 52-week high on Tuesday, as the company received final approval from the US health regulator for its generic version of anti-depressant Paxil tablets.
-
Strides Shasun Gets USFDA Nod to Market Dutasteride Capsules
Strides Shasun has received approval from the US health regulator to market Dutasteride capsules, used in treating enlarged prostate gland, in the American market.
-
Pathway Launches 'Liquid Biopsy' to Find Cancer in Healthy People
Pathway Genomics, a company known for pushing the boundaries of direct-to-consumer genetic testing, on Thursday will launch a cancer screening test designed to detect bits of cancer DNA in the blood of otherwise healthy people.
-
Pathway Launches 'Liquid Biopsy' to Find Cancer in Healthy People
Pathway Genomics, a company known for pushing the boundaries of direct-to-consumer genetic testing, on Thursday will launch a cancer screening test designed to detect bits of cancer DNA in the blood of otherwise healthy people.
-
US FDA Approves 'Female Viagra' With Strong Warning
The first drug to treat low sexual desire in women won approval from US health regulators on Tuesday, but with a warning about potentially dangerous low blood pressure and fainting side effects, especially when taken with alcohol.
-
US Health Regulator Says Lead in Maggi Within Acceptable Levels
As a ban continues in India on Nestle's Maggi noodles, the US health regulator USFDA has said its tests have found the lead level in the popular instant food within acceptable levels for US consumers.
-
Glenmark Gets Final Nod From US Drug Regulator for Skin Cream
Glenmark Generics Inc USA, the subsidiary of Glenmark Generics Ltd, has been granted final approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Fluocinonide cream USP (0.1 per cent), Glenmark Pharmaceuticals said in a statement.
